Cagrilintide research peptide — bulk supply for distributors

Regulatory positioning: Clinical trial supply only. Cagrilintide is a patented Novo Nordisk long-acting amylin analogue. Not approved in any jurisdiction as of 2026. Supplied for research and clinical trial supply only — not for commercial distribution in jurisdictions where patent protection is active. Subject to buyer compliance with applicable patent law in the destination jurisdiction.

Overview

Cagrilintide is a long-chain synthetic amylin analogue peptide supplied for research use. Amylin is a 37-amino-acid peptide hormone co-secreted with insulin by pancreatic beta cells, and amylin analogues are of research interest for the study of metabolic pathway dynamics, including glucose handling, satiety signalling, and the interaction of amylin and calcitonin-family receptors. Cagrilintide is a modified long-chain amylin analogue, supplied as a research-grade lyophilized powder, intended for in-vitro receptor-binding studies, cell-based assays, and analytical reference-standard work. SPK Pharma India supplies Cagrilintide as a documented, lot-traceable research compound for distributors, contract manufacturers, and academic laboratories.

Specifications

Research context

Amylin and amylin analogues are a well-studied research area in metabolic biology. Cagrilintide, as a long-chain modified amylin analogue, is used in research contexts that study receptor pharmacology of the amylin receptor (AMY), calcitonin receptor (CTR), and the AMY/CTR heterodimer. In-vitro receptor-binding assays, cell-based signalling assays, and analytical method development for plasma and tissue samples are the typical research applications. Cagrilintide is also used as a research comparator in studies that investigate dual-agonist or triple-agonist peptides, where the amylin pathway is one component of a broader metabolic pathway investigation.

The academic literature on amylin receptor pharmacology and on long-chain amylin analogues is mature, with research-grade assays established for receptor binding, cAMP signalling, and downstream pathway analysis. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The compound is supplied strictly for in-vitro research, analytical method development, and reference-standard work.

For researchers new to the compound, the standard analytical reference points are CAS 1415456-99-3, the approximate molecular weight, the lyophilized powder form, and the documented purity threshold (≥99% HPLC). The full amino acid sequence is disclosed on the lot-matched COA and on the product specification sheet, which is available on request to qualifying trade buyers.

Packaging and supply

• 5 mg research vial — for method development, receptor-binding assays, and reference-standard qualification. Standard MOQ: 5 vials.
• 10 mg research vial — for ongoing research programmes with higher per-assay demand. Standard MOQ: 2 vials.
• Bulk pack — on application, for annual supply contracts and recurring orders.

Distributor pricing is available on application. Annual supply contracts with scheduled recurring dispatch are available for repeat buyers. Lead time for in-stock SKUs is typically 5 business days from purchase order confirmation; lead time for scheduled production is typically 4 to 6 weeks.

Quality and documentation

Every lot of Cagrilintide ships with a lot-matched Certificate of Analysis documenting identity (mass spectrometry and amino acid analysis), purity (HPLC), appearance, lot number, and synthesis batch reference. A representative sample of every lot is independently verified by a third-party analytical laboratory before release. MSDS is supplied with every shipment. The COA template, the lot-traceability workflow, and the third-party verification scope are documented on the Quality page.

Storage and handling

• Store at -20°C in the original sealed container.
• Protect from light and moisture.
• Allow the sealed container to reach room temperature before opening, to avoid condensation.
• Reconstitute in sterile, low-endotoxin research-grade water or in a mild buffer at the working concentration required by the assay.
• Do not refreeze once reconstituted; aliquot and store at working concentration.
• For long-chain peptides, avoid vigorous vortexing; allow gentle dissolution to minimise aggregation.

Shipping

Cagrilintide is shipped lyophilized in sealed vials within temperature-validated packaging. International lanes are routed through dedicated life-science logistics partners with cold-chain handling. Standard dispatch is within 5 business days of purchase order confirmation. SPK Pharma India ships to the United States, the European Union, the United Kingdom, Canada, MENA, APAC, and LATAM. Full export documentation, including commercial invoice, packing list, certificate of origin, COA, and MSDS, is included with every shipment. Destination-specific documentation is supported on request.

Compliance

Cagrilintide is a patented Novo Nordisk long-acting amylin analogue. Not approved in any jurisdiction as of 2026. Supplied for research and clinical trial supply only — not for commercial distribution in jurisdictions where patent protection is active. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The buyer is responsible for end-use classification in the destination jurisdiction, for compliance with applicable patent law, and for ensuring that downstream handling is consistent with the regulatory positioning stated above.

Lead form CTA

To request a wholesale quote for Cagrilintide, contact the trade desk with the subject line "Cagrilintide wholesale quote" and your company details, expected volume, and destination country. Distributor pricing is available on application. The desk responds within one business day.

Related compounds

• Retatrutide 10 mg — triple-agonist research peptide, lyophilized 10 mg vial
• Retatrutide 20 mg — concentrated research vial format
• Ipamorelin — selective GHS pentapeptide research peptide
• Retatrutide 30 mg — bulk research vial format